Rapid access clinic for unexplained lymphadenopathy and suspected malignancy: prospective analysis of 1000 patients

por Kühnl, Andrea, Cunningham, David, Hutka, Margaret, Peckitt, Clare, Rozati, Hamoun, Morano, Federica, Chong, Irene, Gillbanks, Angela, Wotherspoon, Andrew, Harris, Michelle, Murray, Tracey, Chau, Ian
Publicado 2018

Fludarabine-Melphalan-Campath, Followed by Unmanipulated Peripheral-Blood Haematopoietic Stem Cells, Can Still Cure Lymphoma

por Avenoso, Daniele, Alabdulwahab, Amal, Kenyon, Michelle, Mehra, Varun, Krishnamurthy, Pramila, Dazzi, Francesco, Leung, Ye Ting, Anteh, Sandra, Shah, Mili Naresh, Kuhnl, Andrea, Sanderson, Robin, Patten, Piers, Yallop, Deborah, Pagliuca, Antonio, Potter, Victoria
Publicado 2023

Human Herpesvirus 6 Encephalitis Following Axicabtagene Ciloleucel Treatment for Refractory Diffuse Large B Cell Lymphoma

por Shah, Mili, Kuhnl, Andrea, Shields, Gregory, Sudhanva, Malur, Metaxa, Victoria, Wong, Shu, Yallop, Deborah, Patten, Piers, Inam, Shafqat, Hockings, Catherine, Stewart, Orla, Benjamin, Reuben, Cuthill, Kirsty, Pagliuca, Antonio, Potter, Victoria, Sanderson, Robin
Publicado 2021

Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma

por Roddie, Claire, Neill, Lorna, Osborne, Wendy, Iyengar, Sunil, Tholouli, Eleni, Irvine, David, Chaganti, Sridhar, Besley, Caroline, Bloor, Adrian, Jones, Ceri, Uttenthal, Ben, Johnson, Rod, Sanderson, Robin, Cheok, Kathleen, Marzolini, Maria, Townsend, William, O'Reilly, Maeve, Kirkwood, Amy A., Kuhnl, Andrea
Publicado 2023

Early FDG-PET response predicts CAR-T failure in large B-cell lymphoma

por Kuhnl, Andrea, Roddie, Claire, Kirkwood, Amy A., Menne, Tobias, Cuadrado, Maria, Marzolini, Maria A. V., Osborne, Wendy, Sanderson, Robin, O’Reilly, Maeve, Townsend, William, Benjamin, Reuben, Potter, Victoria, Patten, Piers E. M., Yallop, Deborah, Voo, Stefan, Petrides, George S., Mulholland, Nicola, Kayani, Irfan
Publicado 2022

Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party

por Penack, Olaf, Peczynski, Christophe, Koenecke, Christian, Polge, Emmanuelle, Kuhnl, Andrea, Fegueux, Nathalie, Daskalakis, Michael, Kröger, Nicolaus, Dreger, Peter, Besley, Caroline, Schanz, Urs, Bloor, Adrian, Ganser, Arnold, Forcade, Edouard, Corral, Lucia López, Passweg, Jakob R, Novak, Urban, Moiseev, Ivan, Schoemans, Hélène, Basak, Grzegorz W, Chabannon, Christian, Sureda, Anna, Averbuch, Dina, Glass, Bertram, de la Camara, Rafael, Peric, Zinaida
Publicado 2023

Results of a United Kingdom real-world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory DLBCL

por Northend, Michael, Wilson, William, Osborne, Wendy, Fox, Christopher P., Davies, Andrew J., El-Sharkawi, Dima, Phillips, Elizabeth H., Sim, Hau Wui, Sadullah, Shalal, Shah, Nimish, Peng, Ying Ying, Qureshi, Iman, Addada, Juanah, Mora, Rocio Figueroa, Phillips, Neil, Kuhnl, Andrea, Davies, Elizabeth, Wrench, David, McKay, Pamela, Karpha, Indrani, Cowley, Anna, Karim, Richard, Challenor, Sarah, Singh, Vikram, Burton, Cathy, Auer, Rebecca, Williams, Chris, Cunningham, Joel, Broom, Angus, Arasaretnam, Anita, Roddie, Claire, Menne, Tobias, Townsend, William
Publicado 2022